ArticleCancers2022

Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired Resistance.

Maxime Cahuzac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.